# WuXi Biologics (Cayman) Inc. (WXIBF)

> Healthcare · CN · Reports in CNY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/WXIBF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | ¥ 21.59B | ¥ 4.87B | ¥ 2.70B | ¥ 3.11B | ¥ 47.27B |
| 2024 | ¥ 18.77B | ¥ 3.37B | ¥ 1.29B | ¥ 4.94B | ¥ 41.82B |
| 2023 | ¥ 17.13B | ¥ 3.42B | ¥ 439.74M | ¥ 4.56B | ¥ 40.33B |
| 2022 | ¥ 15.31B | ¥ 4.43B | ¥ -327.66M | ¥ 4.42B | ¥ 35.05B |
| 2021 | ¥ 10.50B | ¥ 3.46B | ¥ -3.14B | ¥ 4.30B | ¥ 32.28B |
| 2020 | ¥ 5.81B | ¥ 1.75B | ¥ -4.29B | ¥ 3.33B | ¥ 20.56B |
| 2019 | ¥ 4.14B | ¥ 1.05B | ¥ -2.08B | ¥ 2.19B | ¥ 12.78B |
| 2018 | ¥ 2.75B | ¥ 683.58M | ¥ -627.63M | ¥ 0 | ¥ 7.99B |
| 2017 | ¥ 1.79B | ¥ 279.10M | ¥ -342.84M | ¥ 0 | ¥ 4.02B |
| 2016 | ¥ 790.59M | ¥ 99.82M | ¥ -354.36M | ¥ 1.13B | ¥ 270.47M |
| 2015 | ¥ 799.08M | ¥ 63.85M | ¥ -325.94M | ¥ 455.86M | ¥ 146.00M |
| 2014 | ¥ 290.24M | ¥ 36.71M | ¥ -25.84M | ¥ 55.41M | ¥ 371.83M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.23 |
| Current Ratio | 3.14 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 1.33 |

## Other views

- [Metrics](https://sponda.capital/en/WXIBF.md)
- [Charts](https://sponda.capital/en/WXIBF/charts.md)
- [Compare](https://sponda.capital/en/WXIBF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.